Upexi Inc [UPXI] stock is trading at $2.69, down -7.72%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The UPXI shares have lost -20.41% over the last week, with a monthly amount drifted -47.15%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Upexi Inc [NASDAQ: UPXI] stock has seen the most recent analyst activity on August 04, 2025, when Alliance Global Partners initiated its Buy rating and assigned the stock a price target of $15. Previously, Cantor Fitzgerald upgraded its rating to Overweight on June 16, 2025, and kept the price target unchanged to $16.
Upexi Inc [UPXI] stock has fluctuated between $1.90 and $22.57 over the past year. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Upexi Inc [NASDAQ: UPXI] shares were valued at $2.69 at the most recent close of the market. An investor can expect a potential return of 123.05% based on the average UPXI price forecast.
Analyzing the UPXI fundamentals
Upexi Inc [NASDAQ:UPXI] reported sales of 20.69M for the trailing twelve months, which represents a growth of 112.09%. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 2.8%, Pretax Profit Margin comes in at 2.64%, and Net Profit Margin reading is 2.64%. To continue investigating profitability, this company’s Return on Assets is posted at 3.63, Equity is 2.24 and Total Capital is 13.58. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of5.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.52 points at the first support level, and at 2.36 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.99, and for the 2nd resistance point, it is at 3.29.
Ratios To Look Out For
For context, Upexi Inc’s Current Ratio is 3.41. In addition, the Quick Ratio stands at 3.39 and the Cash Ratio stands at 0.02. Considering the valuation of this stock, the price to sales ratio is 7.79, the price to book ratio is 0.75.
Transactions by insiders
Recent insider trading involved Salkind Gene, Director, that happened on Nov 17 ’25 when 100000.0 shares were purchased. Director, Salkind Gene completed a deal on Nov 17 ’25 to buy 100000.0 shares. Meanwhile, Director Salkind Gene bought 20243.0 shares on Jul 11 ’25.
